Cargando…

Therapeutic effect of budesonide/formoterol, montelukast and N-acetylcysteine for bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation

BACKGROUND: Bronchiolitis obliterans syndrome (BOS) after allogeneic hematopoietic stem cell transplantation (HSCT) is currently treated with systemic corticosteroids despite poor efficacy and side effects. This study investigated the therapeutic effect of budesonide/formoterol, montelukast and n-ac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Sei Won, Rhee, Chin Kook, Kim, Yoo Jin, Lee, Seok, Kim, Hee Je, Lee, Jong Wook
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4882858/ https://www.ncbi.nlm.nih.gov/pubmed/27229850 http://dx.doi.org/10.1186/s12931-016-0380-1

Ejemplares similares

Efficacy and safety of high-dose budesonide/formoterol in patients with bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplant
por: Kim, Kyung Hoon, et al.
Publicado: (2020)

Therapeutic effect of budesonide, montelukast and azithromycin on post-infectious bronchiolitis obliterans in children
por: Chen, Xia, et al.
Publicado: (2020)

Follow-up on the therapeutic effects of a budesonide, azithromycin, montelukast, and acetylcysteine (BAMA) regimen in children with post-infectious bronchiolitis obliterans
por: Weng, Tingting, et al.
Publicado: (2021)

LTB4 and montelukast in transplantation-related bronchiolitis obliterans in rats
por: Tu, Zheng-Liang, et al.
Publicado: (2017)

Risk Factor and Clinical Outcome of Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation
por: Rhee, Chin Kook, et al.
Publicado: (2016)

Lung Transplantation for Bronchiolitis Obliterans after Allogeneic Hematopoietic Stem Cell Transplantation
por: Kim, Yu Ri, et al.
Publicado: (2012)

Montelukast for bronchiolitis obliterans syndrome after lung transplantation: A randomized controlled trial
por: Ruttens, David, et al.
Publicado: (2018)

Effects of treatment with montelukast alone, budesonide/formoterol alone and a combination of both in cough variant asthma
por: Yi, Fang, et al.
Publicado: (2022)

Bronchiolitis obliterans
por: King, Talmadge E.
Publicado: (1989)

Postinfectious bronchiolitis obliterans in children: lessons from bronchiolitis obliterans after lung transplantation and hematopoietic stem cell transplantation
por: Yu, Jinho
Publicado: (2015)

Therapeutic comparison of a new budesonide/formoterol pMDI with budesonide pMDI and budesonide/formoterol DPI in asthma
por: Morice, A H, et al.
Publicado: (2007)

A Multicenter, Observational, Prospective Study of the Effectiveness of Switching from Budesonide/Formoterol Turbuhaler(®) to Budesonide/Formoterol Easyhaler(®)
por: Syk, Jörgen, et al.
Publicado: (2019)

Clinical analysis of adenovirus postinfectious bronchiolitis obliterans and nonadenovirus postinfectious bronchiolitis obliterans in children
por: Huang, Fei, et al.
Publicado: (2021)

Bronchiolitis obliterans syndrome after allogeneic hematopoietic SCT: phenotypes and prognosis
por: Bergeron, A, et al.
Publicado: (2012)

Fluticasone, Azithromycin, And Montelukast (FAM) Therapy In Reducing Corticosteroid Exposure In Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell Transplant – A Case Series Of Eight Patients
por: Norman, Brett C., et al.
Publicado: (2010)

Comparative Efficacy of Budesonide/Formoterol with Budesonide, Formoterol or Placebo for Stable Chronic Obstructive Pulmonary Disease: A Meta-Analysis
por: Tang, Bin, et al.
Publicado: (2019)

Correction to: A Multicenter, Observational, Prospective Study of the Effectiveness of Switching from Budesonide/Formoterol Turbuhaler(®) to Budesonide/Formoterol Easyhaler(®)
por: Syk, Jörgen, et al.
Publicado: (2019)

Beyond Bronchiolitis Obliterans: In-Depth Histopathologic Characterization of Bronchiolitis Obliterans Syndrome after Lung Transplantation
por: Vanstapel, Arno, et al.
Publicado: (2021)

Exposure-Response and Clinical Outcome Modeling of Inhaled Budesonide/Formoterol Combination in Asthma Patients
por: Back, Hyun-moon, et al.
Publicado: (2020)

Quantitative CT lung densitometry as an obstructive marker for the diagnosis of bronchiolitis obliterans in children
por: Lee, Hye Jin, et al.
Publicado: (2022)

Budesonide–formoterol (inhalation powder) in the treatment of COPD
por: Ceylan, Erkan
Publicado: (2006)

Comparison of Aerosol Formulations of Formoterol Fumarate and Budesonide
por: Nirale, N. M., et al.
Publicado: (2011)

Budesonide/Glycopyrronium/Formoterol: A Review in COPD
por: Heo, Young-A
Publicado: (2021)

Protocol: Influence of Budesonide and Budesonide/Formoterol on Asthma Control in Smoking Asthmatic Adults
por: Boulet, Louis-Philippe, et al.
Publicado: (2010)

Quantitative CT and pulmonary function in children with post-infectious bronchiolitis obliterans
por: Kim, Jonghyeon, et al.
Publicado: (2019)

Mycoplasma pneumoniae–Associated Bronchiolitis Obliterans Following Acute Bronchiolitis
por: Zhao, Chengsong, et al.
Publicado: (2017)

Lung Clearance Index and Quantitative Computed Tomography of Post-Infectious Bronchiolitis Obliterans in Infants
por: Kim, Yoon Hee, et al.
Publicado: (2017)

Budesonide/Fomoterol in combination with Montelukast in the treatment of Bronchial Asthma
por: Dai, Xiaoxia, et al.
Publicado: (2020)

Budesonide/formoterol combination in COPD: a US perspective
por: Sharafkhaneh, Amir, et al.
Publicado: (2010)

Tolerability of budesonide/formoterol in patients of Kazakhstan rural regions
por: Nurpeissov, Tair, et al.
Publicado: (2015)

Correction to: Budesonide/Glycopyrronium/Formoterol: A Review in COPD
por: Heo, Young-A
Publicado: (2021)

A Case of Bronchiolitis Obliterans Organizing Pneumonia Associated with Adenovirus
por: Jeon, Jin Seok, et al.
Publicado: (1997)

Dermatomyositis without Elevation of Creatine Kinase Presented as Bronchiolitis Obliterans Organizing Pneumonia
por: Lee, Young Ho, et al.
Publicado: (2000)

Analysis of Risk Factors of Bronchiolitis Obliterans in Children with Mycoplasma pneumoniae Bronchiolitis
por: Huang, KunLing, et al.
Publicado: (2022)

Risk Factors for the Development of Post-Infectious Bronchiolitis Obliterans in Children: A Systematic Review and Meta-Analysis
por: Lee, Eun, et al.
Publicado: (2022)

Temozolomide-Associated Bronchiolitis Obliterans Organizing Pneumonia Successfully Treated with High-Dose Corticosteroid
por: Kim, Tae-Ok, et al.
Publicado: (2012)

Rituximab-Induced Bronchiolitis Obliterans Organizing Pneumonia
por: Ergin, Ahmet B., et al.
Publicado: (2012)

Upregulation of elastin expression in constrictive bronchiolitis obliterans
por: Shifren, Adrian, et al.
Publicado: (2007)

Quinine-induced bronchiolitis obliterans and organizing pneumonia
por: Rahman, Masoodur, et al.
Publicado: (2012)

Bortezomib-Induced Bronchiolitis Obliterans Organizing Pneumonia
por: Vandeix, E., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_91s6qrd2tjdqn75g4mkd9h8n8g